Strides Arcolab has reported results for first quarter ended June 30, 2014.
The company’s net profit jumped over 12 fold at Rs 26.80 crore as compared to Rs 2.16 crore for the quarter ended June 30, 2013. The company’s total income has surged by 22.95% to Rs 226.28 crore for the quarter under review from Rs 184.04 crore for the corresponding quarter of the previous year.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
